WOLVERINE TRADING, LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 129 filers reported holding INTERSECT ENT INC in Q2 2017. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2020$236,000
-40.6%
18,400
-46.1%
0.00%
Q1 2020$397,000
+36.0%
34,116
+190.6%
0.00%
-100.0%
Q4 2019$292,000
+67.8%
11,741
+11.8%
0.00%0.0%
Q3 2019$174,000
-81.9%
10,500
-75.1%
0.00%
-66.7%
Q2 2019$959,000
-49.3%
42,100
-28.4%
0.00%
-50.0%
Q1 2019$1,890,000
+0.4%
58,800
-10.2%
0.01%
+100.0%
Q3 2018$1,882,000
+451.9%
65,452
+522.6%
0.00%
+200.0%
Q4 2017$341,000
-7.3%
10,512
-22.7%
0.00%
-50.0%
Q2 2017$368,000
+111.5%
13,600
+35.7%
0.00%
+100.0%
Q1 2017$174,00010,0190.00%
Other shareholders
INTERSECT ENT INC shareholders Q2 2017
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 238,698$3,781,0003.74%
PURA VIDA INVESTMENTS, LLC 275,000$4,356,0001.32%
Broadfin Capital, LLC 638,600$10,115,0000.91%
Aisling Capital LLC 248,498$3,936,0000.81%
Bellevue Group AG 205,325$3,252,0000.59%
Iguana Healthcare Management, LLC 180,000$2,852,0000.51%
Rock Springs Capital Management LP 345,000$5,465,0000.34%
SECTORAL ASSET MANAGEMENT INC 168,140$2,663,0000.26%
FORMULA GROWTH LTD 62,213$985,0000.22%
MENTA CAPITAL LLC 111,915$1,773,0000.17%
View complete list of INTERSECT ENT INC shareholders